The Brazilian Ministry of Health reported that the country will receive between 10 and 14 million doses of the AstraZeneca/Oxford vaccine from Covax, the global initiative from World Health Organization (WHO) to ensure rapid and equitable access to COVID-19 vaccines for all countries.
The vaccine doses will start arriving in Brazil in February, but will not arrive in a single batch. According to the newspaper Valor Econômico, the estimate is that up to 35% of the total batch of vaccines arrive by March and the rest by June.
Brazil will receive the AstraZeneca/Oxford vaccine produced by two different suppliers, the Serum Institute, from India, and the SK Institute, from South Korea – both versions of the vaccine will be approved by the WHO at the beginning of February.
The AstraZeneca/Oxford vaccine produced by the Indian laboratory is already used in Brazil on an emergency basis; the first batch, with 2 million doses, came from India and has already been distributed by the Federal Government to the states.
So far, according to Our World in Data, from the University of Oxford, Brazil has already given 2.07 million shots of vaccine against COVID-19.